87.26
0.44 (0.51%)
0.44 (0.51%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 8,800,396 |
|
|||||
| News | (1) | ||||||
| Day High | 87.53 | Low High |
|||||
| Day Low | 86.02 | ||||||
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Merck and Co Inc | MRK | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| 0.44 | 0.51% | 87.26 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 86.53 | 86.02 | 87.53 | 87.41 | 86.82 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 97,477 | 8,800,396 | $ 87.09 | $ 766,405,587 | - | 70.89 - 95.72 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:21 | 1 | $ 87.26 | USD |
Period:
Draw Mode:
Merck and Co Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 220.66B | 2.53B | 2.53B | $ 50.16B | $ 14.55B | 5.14 | 13.60 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 2.64 | 3.15% | 09/14/22 | 761.23k | 0.10% |
Merck News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRK Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 89.98 | 91.08 | 86.02 | 88.18 | 9,180,946 | -2.72 | -3.02% |
| 1 Month | 92.69 | 95.35 | 86.02 | 90.94 | 8,485,766 | -5.43 | -5.86% |
| 3 Months | 90.70 | 95.72 | 83.05 | 90.67 | 11,164,586 | -3.44 | -3.79% |
| 6 Months | 78.80 | 95.72 | 72.875 | 85.79 | 11,413,660 | 8.46 | 10.74% |
| 1 Year | 75.51 | 95.72 | 70.89 | 81.77 | 12,738,539 | 11.75 | 15.56% |
| 3 Years | 83.85 | 95.72 | 65.25 | 80.63 | 11,042,355 | 3.41 | 4.07% |
| 5 Years | 62.95 | 95.72 | 52.83 | 75.84 | 10,733,036 | 24.31 | 38.62% |
Merck Description
| Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States. |